Corvus Pharmaceuticals Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 42
Employees
  • Stock Symbol
  • CRVS
Stock Symbol
  • Share Price
  • $2.25
  • (As of Friday Closing)

Corvus Pharmaceuticals General Information

Description

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the most critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers and autoimmune diseases. The company's lead product candidate is CPI-006 which is a potent humanized monoclonal antibody that is designed to react with a specific site on CD73. Its other product candidates are CPI-818, CPI-935, CPI-182 and Ciforadenant.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 863 Mitten Road
  • Suite 102
  • Burlingame, CA 94010
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Corvus Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.25 $2.20 $1.86 - $9.54 $105M 46.5M 687K $0.08

Corvus Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 140,642 51,076 69,000 (15,174)
Revenue 0 0 0 0
EBITDA (6,143) (5,903) (48,111) (48,375)
Net Income (6,658) (5,995) (46,672) (46,939)
Total Assets 119,323 85,529 83,646 118,232
Total Debt 3,885 2,310 3,188 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Corvus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Corvus Pharmaceuticals‘s full profile, request access.

Request a free trial

Corvus Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Corvus Pharmaceuticals‘s full profile, request access.

Request a free trial

Corvus Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target
Drug Discovery
Burlingame, CA
42 As of 2020
00000
000000 - 000 00000

00000000

t nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt m
0000000000000
San Diego, CA
000 As of 0000
00000
000000000 - 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Corvus Pharmaceuticals Competitors (52)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
000000 00000000000 Venture Capital-Backed Plymouth Meeting, PA 0 000.00 00000000000 000.00
0000 000000 Venture Capital-Backed South San Francisco, CA 000 00000 00000000000 00000
You’re viewing 5 of 52 competitors. Get the full list »

Corvus Pharmaceuticals Patents

Corvus Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019377454-A1 B-cell activating cd73 antibodies Pending 05-Nov-2018 000000000
CA-3118706-A1 B-cell activating cd73 antibodies Pending 05-Nov-2018 000000000
EP-3880710-A2 B-cell activating cd73 antibodies Pending 05-Nov-2018 000000000
US-20200079793-A1 Compounds and methods for modulating adenosine a2b receptor and adenosine a2a receptor Abandoned 31-Aug-2018 0000000000
EP-3616753-A1 Compounds for modulating adenosine a2b receptor and adenosine a2a receptor Withdrawn 31-Aug-2018 C07D513/04 0
To view Corvus Pharmaceuticals’s complete patent history, request access »

Corvus Pharmaceuticals Executive Team (11)

Name Title Board Seat Contact Info
Richard Miller MD Chief Executive Officer & Chairman
Leiv Lea Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Mehrdad Mobasher Chief Medical Officer & Senior Vice President
William Jones Ph.D Senior Vice President
Terry Gould President & Chairman
You’re viewing 5 of 11 executive team members. Get the full list »

Corvus Pharmaceuticals Board Members (10)

Name Representing Role Since
Edith Mitchell Corvus Pharmaceuticals Board Member 000 0000
Ian Clark Self Board Member 000 0000
Linda Grais MD Corvus Pharmaceuticals Board Member 000 0000
Peter Thompson MD Self Co-Founder & Board Member 000 0000
Richard Miller MD Corvus Pharmaceuticals Chief Executive Officer & Chairman 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Corvus Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Corvus Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Corvus Pharmaceuticals‘s full profile, request access.

Request a free trial

Corvus Pharmaceuticals Subsidiaries (1)

Company Name Industry Location Founded
00000 000000000000 Drug Discovery Jiaxing, China 0000
To view Corvus Pharmaceuticals’s complete subsidiaries history, request access »